contingency fielding of the convulsant antidote for nerve ag

File: 970815_may96_decls10_0002.txt
Page: 0002
Total Pages: 2
Subject = contingency fielding of the convulsant antidote for nerve ag    

Parent Organization = XVIII CORPS 

Unit = 24TH ID     

Folder Title = INCOMING MSG  -  DESERT SHIELD  CHEM                                                            

Document Number =         58

Box ID = BX001424










                                                              PT01537    PAGE 02
      PRIORITY           UNCLAS@)IFIED   E F T 0




      SAFETY DATA.     A SUM?4ARY OF THIS INFORMATION WAS PROVIDED TO THE
      CENTCOM SURGEON ON 24 SEP 90.       CBNA TS EXPECTED TO HASTEN THE
      RECOVERY   OF SEVERELY I14TOXICATED NERVE AGENT CASUALTIES TO NC)RMAT
      FUNCTION   AND FACILITATE THE RAPID REGENERATION OF COMBAT POWER.
      3.    CANA' DOCTRINE FOR THE AR14Y# NAVY AND AIR FORCE HAS BEEN
      DEVFLOPER) AND APPROVED By THE COMPONENT SERVFCES IN SUPPORT OF
      OPERATION 6ESFRT SHIELD.      SFRVICF MEf4RER TRAINrNr (IN CONFORMANCE
      WITH TtiTS  DOCTRINE) IS EXPECTFO TO BF STRAIGHT FNRWARD BECAUSE OF
      P RE -E X I ST INr, BASIC SOLDIER SKILLR, IN THE USE OF AUTC)-INJFCTORS.   A
      TRAINING   PACKAGE CAN BE PROVIDED IN ADVANCE OF THE FIRST SHIPMENTS
      OF CANA,   CONTIN(,ENT UPON CINCCENI APPROVAL OF CANA FIELDING.
      4.   IF APPROVED BY FDA AND RFOUESTEO BY CINCCENT* INITIAL STOCKS OF
      CANA COULD BE AVAILABLE FOR StiIPPFNT fO THE THEATRE IN MID-OCTOBER




      PAGE 03 PI)EAf)W[)0003 UNCLAS E F T 0
      1 99 0.
      5.   POINT OF CONTACT FOR THIS ACTION AT THE ARMY SURGEON GEIJEI?AL$S
      OFFICE IS MAJ ROGER MClrqTOSH* MC* OSt4 289-0133 OR COMMERCIAL (7031
      756-0133. P40INT OF CONTACT FOR THF DA NCSOPS IS DR. ROBERT BnYLE9
      DSN 227-3535 OR COMMERCIAL 202-697-3535.
      BT
      91063


      NNNN




























      PRIORITY          UNCLASSIFIED E F T 0